Under construction – not a live service
Sign in
Taking people in EgyptPhase 2/3

Tests ketamine with midazolam for seizures in children before hospital arrival

Tests ketamine added to midazolam for prolonged seizures in children aged 2 to 16.

Plain-language title generated from the registry record
Registry title: Prehospital Early Administration of Ketamine for Status Epilepticus in Epileptic Kids (PEAK-SEEK)

Key facts

Where
Sohag, EgyptSee the site
Phase
Phase 2/3

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 2 and 16 years old?

Source: NCT07095842, who can take part

Where in Egypt

  • Department of Pediatrics at Sohag University HospitalSohag, EgyptTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Sohag University
Trial code
NCT07095842
Record updated
5 August 2025
Original description
The goal of this pragmatic, decentralized, pre-consented, event-driven, randomized controlled trial is to investigate the efficacy of add-on ketamine to second-dose midazolam for prehospital treatment of epileptic children with convulsive status epilepticus.Read full original descriptionShow less

Efficacy of Add-on Ketamine With Second-dose Midazolam for Prehospital Treatment of Epileptic Children With Status Epilepticus

The goal of this pragmatic, decentralized, pre-consented, event-driven, randomized controlled trial is to investigate the efficacy of add-on ketamine to second-dose midazolam for prehospital treatment of epileptic children with convulsive status epilepticus.

Inclusion: Age from 2 to 16 years; Established diagnosis of epilepsy of at least 1 year duration; History of at least 1 episode of convulsive status epilepticus in the preceding 12 months.

Exclusion: Failure to obtain informed consent; Known allergies or contraindications to ketamine; Known contraindications to intramuscular injection; Presence of another family member included in the same trial; Having subsequent events (only the index event will be included).

ClinicalTrials.gov NCT07095842